BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
VEGFA
,
Angiogenesis
,
Breast Cancer
,
Prostate
,
Neocentromeres
,
Fenofibrate
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
endometrial cancer
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
MSH6
CDH1
MSH3
PTEN
ENO1
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
regulation of nitrogen compound metabolic process
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
FISCHER_DREAM_TARGETS
PILON_KLF1_TARGETS_DN
SMID_BREAST_CANCER_NORMAL_LIKE_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Expression patterns in endometrial cancer
Endometrial cancer tissues; and SPAC-1L cells depleted of STAT1 and/or treated with IFN-g
expO project: Endometrial cancer subset
Endometrial cancer Ishikawa cells with SF3B1 siRNA knockdown
Endometrial cancer Ishikawa cells with NFAT5 gene overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for endometrial cancer
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Adipocytokines in Endometrial Cancer
Molecular Staging of Endometrial Cancer
Vibrational Spectroscopy for Endometrial Cancer Diagnosis
Role of Senescence in the Development of Endometrial Cancer
Adipocytokines in Endometrial Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ